Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas. (Q54298509)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

1 reference

based on heuristic

inferred from title

author name string

Yi-Li Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Chao Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Xuan-xuan Dai

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Xiao-Hua Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Ou-Chen Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

publication date

2 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

29

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

3360-3366

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA deregulation in human thyroid papillary carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

The role of microRNA genes in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Role of NF-kappaB in thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0315-8

21 January 2018

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22855362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eicosanoid Regulation of Vascular Endothelial Growth Factor Expression and Angiogenesis in Microvessel Endothelial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22855362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-012-0315-8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22855362

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54298509&oldid=2212414063"